3M (MMM) Offering Possible 21.95% Return Over the Next 28 Calendar Days

3M's most recent trend suggests a bullish bias. One trading opportunity on 3M is a Bull Put Spread using a strike $140.00 short put and a strike $130.00 long put offers a potential 21.95% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $140.00 by expiration. The full premium credit of $1.80 would be kept by the premium seller. The risk of $8.20 would be incurred if the stock dropped below the $130.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for 3M is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for 3M is bullish.

The RSI indicator is at 63.08 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for 3M

Canadian hospitals prepare to sterilize, re-use N95 masks if supplies dwindle
Wed, 15 Apr 2020 18:08:20 +0000
Some Canadian hospitals are collecting used N95 masks so that they can be decontaminated and worn again should new ones become impossible to find amid a global scramble for personal protective equipment caused by the coronavirus pandemic. The issue has become more pressing in Canada after the United States blocked some exports of protective gear. On April 5, Canada's chief medical officer, Theresa Tam, said hospitals should not throw away medical masks, including N95 respirators, because it may be possible to disinfect and re-use them.

3M Teams Up With Cummins to Increase Filter Output for PAPRs
Wed, 15 Apr 2020 13:00:01 +0000
3M (MMM) partners with Cummins to increase the production of filters for its powered air-purifying respirators to fight against the coronavirus pandemic.

Fastenal Is One Company That Got Pandemic Planning Right
Wed, 15 Apr 2020 12:30:23 +0000
(Bloomberg Opinion) — As a distributor of factory-floor basics, Fastenal Co.’s earnings are typically a reasonable guide of what's to come when its manufacturing customers report results a few weeks later, and that should hold even in the coronavirus era. But listening to the company’s conference call on Tuesday to discuss its first-quarter results, I was struck by a different kind of roadmap: In step-by-step fashion, CEO Dan Florness laid out Fastenal's response to the coronavirus crisis, offering a case study on best practices when preparing for the disruptions of a pandemic.Fastenal is little known outside of industrial circles, but it's essentially in the business of supply-chain management, and it acted on the warning signs of the coronavirus crisis much faster than the federal government. That's partly a reflection of the nature of Fastenal's supply chain, which is weighted heavily toward Asia, the first frontier of the outbreak. Way back in January, as the spread of the virus forced China into lockdown, Fastenal began monitoring certain product lines to ensure a reliable flow of goods for its customers, Florness said Tuesday as he kicked off the earnings conversation. This is around the time that an array of top government officials began warning of the risks the coronavirus posed to the U.S., even as President Donald Trump publicly downplayed the threat and the prospect of upheaval to Americans’ daily lives, according to a detailed report from the New York Times.The initial focus of the administration's coronavirus task force (formally announced on Jan. 29) was on keeping infected Chinese people out of the U.S., not on testing or supplies, the Washington Post reported. Procurement has since become the government's biggest problem. The federal stockpile of key medical equipment is woefully inadequate to address a pandemic on the scale of the coronavirus and governors across the country have been forced to compete against each other on the open market for masks and ventilators. Fastenal, by contrast, has recent experience when it comes to a nimble rethinking of supply chains, thanks in part to Trump's trade wars. “Quite frankly, after the tariffs became a thing, we began to beat the bushes for additional suppliers outside of China,” CFO Holden Lewis said in a phone interview Tuesday. “I'd love to tell you we moved at lightning pace specifically related to the coronavirus, but we already had the platform in place that allowed us to react to this in the way that we have." The company’s Asian procurement and quality-control infrastructure has been in place for years.Fastenal sounded internal alarms on Feb. 6 for all of its employees to prepare to marshal resources and vet backup suppliers for certain janitorial and protective-gear products it sells. “It's an unforeseen problem," Trump said of the virus on March 6 as he signed an initial spending bill that included just $3.1 billion to stockpile medical supplies. "Came out of nowhere.” Federal agencies largely waited until mid-March to begin placing bulk orders of N95 respirator masks, mechanical ventilators and other equipment needed by front-line health-care workers, according to a review of purchasing contracts by the Associated Press. By that point, Fastenal had moved to limit the sales of certain key cleaning and health-care products to critical industries to help ensure that the goods made it to the workers that needed them the most. While the government has sporadically invoked the Defense Production Act to spur companies into ramping up the production of ventilators and masks, a concrete plan regarding the distribution of this vital equipment among the states was late in development and is still lacking.Fastenal's efforts to procure alternative sources of personal protective equipment and funnel goods to those most in need has meant that its supply chain is "pretty filled,” CFO Lewis said on the earnings call Tuesday. "Right now we still have product that we’re going to be working through delivering throughout most of April." Ultimately, these efforts may even help the company bring in new business, CEO Florness said. There are multiple examples of customers reaching out to the Fastenal’s sales team, saying “’I get what your supply-chain resources are about more than ever from what I’ve seen firsthand over the last three weeks,’” he said. Imagine what the world would be like right now if governors were praising the Trump administration's supply-chain resources rather than desperately pleading for needed goods and evaluating sending in the state national guard to protect shipments of masks from seizure by the federal government. This is not the only front on which Fastenal has been ahead of the curve. Like many other companies, it didn’t wait for federal government orders to implement social-distancing measures. On March 6, Fastenal canceled an annual sales event that was meant to take place in mid-April. Doing so deprived it of one of its biggest opportunities to ink new contracts for its onsite supply-chain services and vending machines  — and it’s one reason why 2020 growth prospects are “murky,” Florness said. But it was the "prudent” thing to do, he said. The weekend of March 14, the company closed off public access to its retail locations.(1) That Monday, March 16, the Trump administration announced national guidelines to slow the spread of the coronavirus, including avoiding gatherings of more than 10 people. Fastenal has also expanded paid time-off for both full- and part-time employees to deal with coronavirus disruptions. All of this hasn't saved Fastenal from the coronavirus. While sales of safety products jumped 31% in March, revenue from Fastenal’s traditional fasteners business plunged 10.1% as factories, amusement parks, retail outlets and schools shuttered. On average, daily sales across the company increased 0.2% in March, a marked drop from the 4.7% pace in February. And because safety products are typically lower-margin, that contributed to the 110 basis-point drop in the first quarter in the percentage of sales Fastenal converts into gross profit. Still, the coronavirus crisis is different than the 2009 recession because at least demand is increasing for some products. April sales are down about 10.5% to date, which is relatively mild in the scheme of things and encouraging ahead of results due later this month from companies such as 3M Co. and Honeywell International Inc. While headcount may decline, Fastenal indicated that at this point, any cuts are unlikely to be of the magnitude they were back in 2009. The margin dislocation also will likely fix itself once demand for fasteners bounces back and the need for protective gear eases. Fastenal may be leaving some money on the table when it comes to safety and cleaning products, but it put in strict pricing guidelines early on in the process "because we're more interested in getting through this and getting society through it and getting back to whatever the new normal is,” Florness said. In more ways than one, this is a company that got pandemic planning right. (1) Most of the company's business comes through onsite or delivery services that remain operational for those customers serving critical industries, but profit margins tend to be higher for products purchased through its retail locations, so the closure cost the company on that front.This column does not necessarily reflect the opinion of Bloomberg LP and its owners.Brooke Sutherland is a Bloomberg Opinion columnist covering deals and industrial companies. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

3M sues another mask merchant, alleging price gouging
Wed, 15 Apr 2020 11:49:15 +0000
3M Co. is suing a Florida company, alleging the supplier attempted to charge "grossly inflated prices" for N95 respirators — the sought-after masks used to guard against the coronavirus — to the U.S. Strategic National Stockpile and blame 3M for the markup.

3M Files Lawsuit in Florida in Alleged N95 Price Gouging Attempt of the Strategic National Stockpile
Tue, 14 Apr 2020 22:17:00 +0000
3M filed a legal action today in federal court in Florida against an Orlando-based defendant that twice attempted to fraudulently sell tens of millions of likely nonexistent 3M N95 respirators at grossly inflated prices to the federal Division of Strategic National Stockpile, all the while falsely affiliating itself with 3M.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.